Abstract:Background: Paclitaxel is a natural anticancer drug, which has demonstrated significant activity in clinical trials. However, it has been limited due to poor aqueous solubility. Chitosan can be modified into graft copolymer, which changed into nanoparticles in aqueous solution, and employed as controlled release carriers for drugs. Objective: To study the characterization, in addition, to evaluate in vitro drug release ability of paclitaxel nanoparticles. Design, time and setting: A repeated measurement design was conducted at the Laboratory of North China Coal Medical University from January 2008 to July 2008. Materials: The average molecular weight of 2.0 × 10 5 chitosan with 92% deacetylation degree was produced by Golden-shell Biochemical Co., Ltd. Paclitaxel (lot number: 082329802) was provided by National Institute for the Control of Pharmaceutical and Biological Products. Methods: The potassium diperiodaton-ickelate served as initiator, chitosan-graft-vinyl acetate copolymers were synthesized by free radical graft copolymerization, which could be directly transformed into nanoparticles with hydrophobic core and hydrophilic surface in the water medium. Paclitaxel nanopartioles were prepared via mixture 0.5-5.0 mg paclitaxel with nanoparticles by ultrasonic irradiation technology. Main outcome measures: Particles size, polydispersity index zeta potential was detected by laser particle size analyzer. The morphology of chitosan nanoparticles and paclitaxel nanoparticles was observed by transmission electron microscope. In addition, encapsulation capability, loading content and in vitro drug release of the paclitaxel nanoparticles was analyzed by high-performance liquid chromatography. Results: The mean diameters of chitosan nanoparticles and paclitaxel nanoparticles were 196.2 nm and 320.8 nm, respectively. The nanoparticles possessed a uniform particles size distribution and an obvious positive charge surface, but the Zeta potential had no significant difference (F=0.818, F=3.38, all P > 0.05). The dose of paclitaxel could affect the encapsulation rate, which could up to 93.6% when added the quantity of paclitaxel was 2% of anoparticles. The results of simulate drug release showed that drug release was reach 48.3% in 24 hours at the burst release phase, which up to 75.9% at 175 hours longer in the slower release phase. The encapsulation rate of drug-loaded nanoparticles was stable. Conclusion: The preparation method is reliable and simple. The nanoparticles possessed good physical performance and sustained release character in vitro.

Effects of amphiphilic chitosan-g-poly(ε-caprolactone) polymer additives on paclitaxel release from drug eluting implants.

Chitosan-poly(ε-caprolactone)-poly(ethylene glycol) graft copolymers: synthesis, self-assembly, and drug release behavior.

PCL films incorporated with paclitaxel/5-fluorouracil: Effects of formulation and spacial architecture on drug release.

CONTROLLED RELEASE OF SALICYLIC ACID FROM ELECTROSPUN MATS OF POLY(Ε-CAPROLACTONE) WITH LOW CRYSTALLINITY

Treatments of paclitaxel with poly(vinyl pyrrolidone) to improve drug release from poly(ε-caprolactone) matrix for film-based stent

Photo-crosslinked Poly(ethylene Glycol)-B-poly(ϵ-caprolactone) Nanoparticles for Controllable Paclitaxel Release

Computational studies on self-assembled paclitaxel structures: Templates for hierarchical block copolymer assemblies and sustained drug release

Evaluation of Two Polymeric Blends (EVA/PLA and EVA/PEG) As Coating Film Materials for Paclitaxel-Eluting Stent Application

Synthesis, characterization, and application of amino-terminated poly(ethylene glycol)-block-poly(ε-caprolactone) copolymer for paclitaxel

Electrospun Poly-lactic Acid/Chitosan Nanofibers Loaded with Paclitaxel for Coating of a Prototype Polymeric Stent

Synthesis, Characterization, And Application Of Amino-Terminated Poly(Ethylene Glycol)-Block-Poly(Epsilon-Caprolactone) Copolymer For Paclitaxel

Effects of Amphiphilic Pcl-Peg-Pcl Copolymer Addition on 5-Fluorouracil Release from Biodegradable Pcl Films for Stent Application

Incorporation of paclitaxel solid dispersions with poloxamer188 or polyethylene glycol to tune drug release from poly(ε-caprolactone) films

Shell Cross-Linked Stearic Acid Grafted Chitosan Oligosaccharide Self-Aggregated Micelles for Controlled Release of Paclitaxel.

In Vitro and in Vivo Characterization of A Coronary Stent Coated with an Elastic Biodegradable Polymer for the Sustained Release of Paclitaxel

In Vitro Evaluation and Finite Element Simulation of Drug Release from Polydiacetylene-Polyethylene Glycol Stearate Nanovesicles

Effects of Copolymer Component on the Properties of Phosphorylcholine Micelles.

Preparation, characterization and drug release property of paclitaxel nanoparticles

Preparation and Characterization of Poly(lactic Acid)–poly(ethylene Glycol)–poly(lactic Acid) (PLA–PEG–PLA) Microspheres for Controlled Release of Paclitaxel

Effect of Polymer Degradation on Prolonged Release of Paclitaxel from Filomicelles of Polylactide/poly(ethylene Glycol) Block Copolymers.

Amphiphilic Nanoparticles Based on Poly(Vinyl Pyrrolidone) and Stearoyl Modified Chitosan As Drug Vehicles for Paclitaxel Delivery